$7.39
5.98% today
Nasdaq, Apr 04, 08:45 pm CET
ISIN
CA35954B2066
Symbol
QNTM

FSD Pharma Inc Stock price

$7.86
+3.57 83.00% 1M
+3.94 100.41% 6M
+4.18 113.59% YTD
-35.02 81.67% 1Y
-50.84 86.61% 3Y
-191.04 96.05% 5Y
-1,118.34 99.30% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.18 2.24%
ISIN
CA35954B2066
Symbol
QNTM

Key metrics

Market capitalization $15.09m
Enterprise Value $6.81m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 1.57
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-15.86m
Free Cash Flow (TTM) Free Cash Flow $-6.74m
Cash position $8.06m
EPS (TTM) EPS $-14.47
P/S forward 1.08
EV/Sales forward 0.25
Short interest 8.53%
Show more

Is FSD Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

FSD Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast FSD Pharma Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast FSD Pharma Inc:

Buy
100%

Financial data from FSD Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 0.49 0.49
80% 80%
-
-0.49 -0.49
80% 80%
-
- Selling and Administrative Expenses 8.79 8.79
15% 15%
-
- Research and Development Expense 6.08 6.08
58% 58%
-
-15 -15
8% 8%
-
- Depreciation and Amortization 0.49 0.49
80% 80%
-
EBIT (Operating Income) EBIT -16 -16
17% 17%
-
Net Profit -14 -14
22% 22%
-

In millions USD.

Don't miss a Thing! We will send you all news about FSD Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

FSD Pharma Inc Stock News

Neutral
GlobeNewsWire
one day ago
Alcohol Detoxification and Anti-Hangover Beverage (Available on amazon.com and unbuzzd.com ) to be Distributed by FUSION in Puerto Rico and Caribbean Region TORONTO, April 03, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), today announced its licensee – Celly Nutrition Corporation (“Celly Nutrition”), the company beh...
Neutral
GlobeNewsWire
4 days ago
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that on March 31, 2025 it has entered into a joint clinical study with Massachusetts General Hospital (MGH) scientists to validate a nov...
Neutral
GlobeNewsWire
4 days ago
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”) is pleased to announce that it has closed the final tranche (“Final Tranche”) of the offering announced on December 5, 2024 (the “December 5 NR”) as amended on January 20, 2025, and based on the better terms announced on March 7, 2025 (the “March 7 NR”...
More FSD Pharma Inc News

Company Profile

FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. FSD Pharma Inc. has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and collaborative research and development agreement with Solarvest BioEnergy Inc. The company is headquartered in Cobourg, Canada.

Head office Canada
CEO Zeeshan Saeed
Employees 7
Founded 1994
Website www.quantumbiopharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today